ES2027773T3 - Dispositivo auto-adhesivo para administracion de un principio activo por via percutanea. - Google Patents

Dispositivo auto-adhesivo para administracion de un principio activo por via percutanea.

Info

Publication number
ES2027773T3
ES2027773T3 ES198888400625T ES88400625T ES2027773T3 ES 2027773 T3 ES2027773 T3 ES 2027773T3 ES 198888400625 T ES198888400625 T ES 198888400625T ES 88400625 T ES88400625 T ES 88400625T ES 2027773 T3 ES2027773 T3 ES 2027773T3
Authority
ES
Spain
Prior art keywords
weight
parts
administration
self
percutanea
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198888400625T
Other languages
English (en)
Inventor
Alain Guillemet
Eric Teillaud
Philippe Reginault
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires D'hygiene Et De Dietetique Lhd SA
Original Assignee
Laboratoires D'hygiene Et De Dietetique Lhd SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires D'hygiene Et De Dietetique Lhd SA filed Critical Laboratoires D'hygiene Et De Dietetique Lhd SA
Application granted granted Critical
Publication of ES2027773T3 publication Critical patent/ES2027773T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

EL PRESENTE INVENTO TRATA DE UNA NUEVA MATRIZ AUTO SIVA PARA LA ADMINISTRACION PERCUTANEA DE UN PRINCIPIO ACTIVO. ESTA MATRIZ COMPRENDE EN ASOCIACION: A) DE 40 A 60 PARTES EN PESO DE COPOLIMERO DE ETILENO Y DE ACETATO DE VINILO, B) DE 40 A 60 PARTES EN PESO DE ALCOHOL ALIFATICO SUPERIOR, C) DE 1 A 20 PARTES EN PESO DERIVADO DE CELULOSA, D) DE 0,1 A 8 PARTES EN PESO DE ALCOHOL POLIHIDRICO, Y E) DE 0,01 A 10 PARTES EN PESO DE PRINCIPIO ACTIVO ADMINISTRABLE POR VIA PERCUTANEA. LA RELACION EN PESO A + C/ B + D ESTA COMPRENDIDA ENTRE 0,7 Y 1,3.
ES198888400625T 1987-03-25 1988-03-16 Dispositivo auto-adhesivo para administracion de un principio activo por via percutanea. Expired - Lifetime ES2027773T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8704133A FR2612785A1 (fr) 1987-03-25 1987-03-25 Dispositif auto-adhesif d'administration d'un principe actif par voie percutanee

Publications (1)

Publication Number Publication Date
ES2027773T3 true ES2027773T3 (es) 1992-06-16

Family

ID=9349406

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198888400625T Expired - Lifetime ES2027773T3 (es) 1987-03-25 1988-03-16 Dispositivo auto-adhesivo para administracion de un principio activo por via percutanea.

Country Status (9)

Country Link
US (1) US4842864A (es)
EP (1) EP0288336B1 (es)
JP (1) JPH0780758B2 (es)
AT (1) ATE69724T1 (es)
DE (1) DE3866408D1 (es)
ES (1) ES2027773T3 (es)
FR (1) FR2612785A1 (es)
GR (1) GR3003887T3 (es)
PT (1) PT87029B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4814168A (en) * 1988-03-04 1989-03-21 Noven Pharmaceuticals, Inc. Transdermal multipolymer drug delivery system
FR2635979B1 (fr) * 1988-09-07 1992-05-29 Lhd Lab Hygiene Dietetique Dispositif auto-adhesif d'administration d'un principe actif par voie percutanee
WO1990006120A1 (en) * 1988-12-01 1990-06-14 Schering Corporation Compositions for transdermal delivery of estradiol
JP2788754B2 (ja) * 1989-05-12 1998-08-20 日東電工株式会社 シート状経皮吸収デバイス
IN172390B (es) * 1989-07-18 1993-07-10 Ethicon Inc
WO1991005529A1 (en) * 1989-10-13 1991-05-02 Watson Laboratories, Inc. Drug delivery systems and matrix therefor
US5518734A (en) * 1991-09-25 1996-05-21 Beta Pharmaceuticals Co. Transdermal delivery system for estradiol and process for manufacturing said device
US5705185A (en) * 1991-09-25 1998-01-06 Beta Pharmaceuticals Co. Transdermal delivery of estradiol and process for manufacturing said device
US5827245A (en) * 1992-07-16 1998-10-27 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system comprising the active subtance 17-β-Estradiol (Anhydrous)
DE4237453C1 (es) * 1992-11-06 1993-08-19 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
DE4333595A1 (de) * 1993-10-01 1995-04-06 Labtec Gmbh Transdermales therapeutisches System zur Applikation von Arzneimitteln auf die Haut
FR2717688B1 (fr) * 1994-03-28 1996-07-05 Lhd Lab Hygiene Dietetique Système matriciel transdermique d'administration d'un oestrogène et/ou un progestatif à base d'EVA.
DE4416927C1 (de) * 1994-05-13 1995-08-31 Lohmann Therapie Syst Lts Vorrichtung zur Abgabe von Wirkstoffen aus Haftschmelzklebern, Verfahren zu ihrer Herstellung und ihre Verwendung
FR2732223B1 (fr) * 1995-03-30 1997-06-13 Sanofi Sa Composition pharmaceutique pour administration transdermique
FR2739032B1 (fr) * 1995-09-27 1997-11-21 Lhd Lab Hygiene Dietetique Systeme matriciel transdermique d'administration d'un oestrogene et/ou d'un progestatif a base d'eva, procede de preparation et utilisation en therapeutique
WO2001052823A2 (en) * 2000-01-20 2001-07-26 Noven Pharmaceuticals, Inc. Compositions to effect the release profile in the transdermal administration of drugs
DE10303537A1 (de) * 2003-01-29 2004-08-05 Tesa Ag Selbstklebende, hochtransparente Schutzfolie für Automobilscheiben und andere empfindliche Oberflächen
JP4782438B2 (ja) * 2005-02-17 2011-09-28 日東電工株式会社 貼付製剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2542998B1 (fr) * 1983-03-24 1986-01-31 Rhone Poulenc Sante Nouvelle forme transdermale du dinitrate d'isosorbide
CA1248450A (en) * 1984-04-05 1989-01-10 Kazuo Kigasawa Soft patch
JPS615012A (ja) * 1984-06-11 1986-01-10 Dai Ichi Seiyaku Co Ltd 貼付剤
AU563054B2 (en) * 1984-10-24 1987-06-25 Sekisui Kagaku Kogyo Kabushiki Kaisha Percutaneous tape of isdn
US4615699A (en) * 1985-05-03 1986-10-07 Alza Corporation Transdermal delivery system for delivering nitroglycerin at high transdermal fluxes
DE3518707A1 (de) * 1985-05-24 1986-11-27 Beiersdorf Ag, 2000 Hamburg Nitro-pflaster
JPS61280426A (ja) * 1985-06-04 1986-12-11 Ikeda Mohandou:Kk 消炎鎮痛用貼付剤
JPH0747535B2 (ja) * 1985-11-26 1995-05-24 日東電工株式会社 消炎鎮痛用貼付剤
DE3617158C2 (de) * 1986-05-22 1994-10-06 Lohmann Therapie Syst Lts Transdermales Arzneimittel

Also Published As

Publication number Publication date
US4842864A (en) 1989-06-27
PT87029B (pt) 1992-06-30
DE3866408D1 (de) 1992-01-09
JPS63255217A (ja) 1988-10-21
ATE69724T1 (de) 1991-12-15
EP0288336B1 (fr) 1991-11-27
JPH0780758B2 (ja) 1995-08-30
EP0288336A1 (fr) 1988-10-26
PT87029A (pt) 1988-04-01
FR2612785A1 (fr) 1988-09-30
GR3003887T3 (es) 1993-03-16

Similar Documents

Publication Publication Date Title
ES2027773T3 (es) Dispositivo auto-adhesivo para administracion de un principio activo por via percutanea.
MXPA01012659A (es) Nueva forma de administracion y preparacion que comprende un compuesto activo labil acido.
IE873125L (en) Benzimidazole derivatives
EP0221041A3 (en) Benzimidazole derivatives, process for their preparation and their pharmaceutical use
ES2159591T3 (es) Composicion de liberacion controlada.
EP0852117A4 (en) IMPROVEMENT OF LIPID METABOLISM
DE3860550D1 (de) Pharmazeutische zubereitung fuer perkutane verabreichung, die eperison oder tolperison oder eines ihrer salze enthaelt.
DE3766200D1 (de) L-dopa enthaltendes arzneimittel.
NO870560D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
IL102814A0 (en) Pyrazine derivatives,their preparation and pharmaceutical compositions comprising them
MY101175A (en) External medication
AU3318389A (en) Azelastine-containing medicaments with controlled release of the active substance
GR890100833A (en) Process for the preparation of a compound with gastric inhibitopy effect
ES2062068T3 (es) Dispositivo auto-adhesivo para la administracion de un principio activo por via percutanea.
GB2021409A (en) Pharmaceutical composition
ES2021904A6 (es) Procedimiento para preparar una composicion farmaceutica a base de un acido piperacinacarboxilico.
NO950950L (no) Farmasöytisk preparat
EP0239527A3 (en) Composition adopted for use as a transdermal formulation
JO1519B1 (en) New compounds (new benzimidazole derivatives are effective as ulcers)
KR930700496A (ko) 약물학적 활성을 갖는 s-(2-테노일)-티오젖산 유도체
ATE56144T1 (de) Pharmazeutische zubereitung fuer perkutane verabreichung, die eperison oder tolperison oder eines ihrer salze enthaelt.
JO1653B1 (en) The current benzimidazole is a therapeutically active method for preparing it

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 288336

Country of ref document: ES